17 October 2018 Current Affairs:
Alembic Pharmaceuticals received a tentative approval from the United States Food and Drug Administration (USFDA), the U.S. health regulator for its Alogliptin tablets. The drug is used for the treatment of type 2 diabetes.
The Alogliptin tablets are made in the strengths of 6.25 mg, 12.5 mg and 25mg. The product is a generic version of Takeda Pharms USA’s Nesina tablets.